|
|
|
|
MC803a
Multiple organ tumor tissue array with adjacent normal tissue, including TNM and clinical stage, 40 cases/80 cores, replacing MC803
|
|
| Microarray Panel: | Multiple organ tumor tissue microarray with adjacent normal tissue, containing 7 cases of retinoblastoma, 1 adjacent normal retinal tissue, 11 nephroblastoma, 2 normal renal tissue, 10 neuroblastoma, 2 normal peripheral nerve tissue, 4 lymphocytic leukaemia, 1 granulocytic leukemia, 2 normal spleen tissue, duplicate cores per case |
| Cores: | 80 |
|
| Cases: | 40 |
| Layout: | 10 cols × 8 rows |
| Core Diameter: | 1.5 mm |
| Thickness: | 5 µm | | Quality Control: | Anti-Actin confirmed | | Applications: | Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page. |
| Notes: | Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure. |
*Tissue Microarray Slide Types:
- Unstained: unstained
paraffin
tissue microarray slide.
- Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
- H & E: Hematoxylin and Eosin stained tissue microarray slide.
Microarray Panel Display  | | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | |
| A |
|
|
|
|
|
|
|
|
|
|
|
| B |
|
|
|
|
|
|
|
|
|
|
|
| C |
|
|
|
|
|
|
|
|
|
|
|
| D |
|
|
|
|
|
|
|
|
|
|
|
| E |
|
|
|
|
|
|
|
|
|
|
|
| F |
|
|
|
|
|
|
|
|
|
|
|
| G |
|
|
|
|
|
|
|
|
|
|
|
| H |
|
|
|
|
|
|
|
|
|
|
 |
|
| Legend: | Abd - Abdominal cavity,
Adr - Adrenal gland,
Bon - Bone,
Eye - Eye,
Kid - Kidney,
Lym - Lymph node,
Med - Mediastinum,
Ner - Nerve,
Nos - Nose,
Pel - Pelvic cavity,
Spl - Spleen
- Malignant tumor,
- Malignant tumor,
- Malignant tumor (stage IB),
- Malignant tumor (stage IIA),
- Malignant tumor (stage IIIA),
- Malignant tumor (stage IIc),
- NAT,
- Normal tissue
|
Specification Sheet
| Pos |
No. |
Sex |
Age |
Organ |
Pathology diagnosis |
Stage |
TNM |
Type † |
|
A1 |
1 |
F |
2 |
Eye |
Retinoblastoma |
IB |
T2N0M0 |
Malignant |
|
A2 |
2 |
F |
2 |
Eye |
Retinoblastoma |
IB |
T2N0M0 |
Malignant |
|
A3 |
3 |
F |
1 |
Eye |
Retinoblastoma |
IIIA |
T4aN0M0 |
Malignant |
|
A4 |
4 |
F |
1 |
Eye |
Retinoblastoma |
IIIA |
T4aN0M0 |
Malignant |
|
A5 |
5 |
F |
4 |
Eye |
Retinoblastoma with massive necrosis |
IB |
T2N0M0 |
Malignant |
|
A6 |
6 |
F |
4 |
Eye |
Retinoblastoma with massive necrosis |
IB |
T2N0M0 |
Malignant |
|
A7 |
7 |
M |
2 |
Eye |
Retinoblastoma |
IIA |
T3aN0M0 |
Malignant |
|
A8 |
8 |
M |
2 |
Eye |
Retinoblastoma (sparse) |
IIA |
T3aN0M0 |
Malignant |
|
A9 |
9 |
M |
3 |
Eye |
Retinoblastoma |
IB |
T2N0M0 |
Malignant |
|
A10 |
10 |
M |
3 |
Eye |
Retinoblastoma |
IB |
T2N0M1 |
Malignant |
|
B1 |
11 |
F |
15 |
Eyeball |
Retinoblastoma |
IIc |
T3cN0M0 |
Malignant |
|
B2 |
12 |
F |
15 |
Eyeball |
Retinoblastoma |
IIc |
T3cN0M0 |
Malignant |
|
B3 |
13 |
M |
28 |
Eye |
Retinoblastoma |
IIc |
T3cN0M0 |
Malignant |
|
B4 |
14 |
M |
28 |
Eye |
Retinoblastoma |
IIc |
T3cN0M0 |
Malignant |
|
B5 |
15 |
M |
36 |
Eye |
Cancer adjacent normal retinal tissue |
– |
– |
NAT |
|
B6 |
16 |
M |
36 |
Eye |
Cancer adjacent normal retinal tissue |
– |
– |
NAT |
|
B7 |
17 |
M |
2 |
Kidney |
Nephroblastoma |
– |
– |
Malignant |
|
B8 |
18 |
M |
2 |
Kidney |
Nephroblastoma |
– |
– |
Malignant |
|
B9 |
19 |
M |
2 |
Kidney |
Nephroblastoma |
– |
– |
Malignant |
|
B10 |
20 |
M |
2 |
Kidney |
Nephroblastoma |
– |
– |
Malignant |
|
C1 |
21 |
M |
25 |
Kidney |
Nephroblastoma |
– |
– |
Malignant |
|
C2 |
22 |
M |
25 |
Kidney |
Nephroblastoma |
– |
– |
Malignant |
|
C3 |
23 |
F |
3 |
Kidney |
Nephroblastoma |
– |
– |
Malignant |
|
C4 |
24 |
F |
3 |
Kidney |
Nephroblastoma |
– |
– |
Malignant |
|
C5 |
25 |
M |
4 |
Kidney |
Nephroblastoma |
– |
– |
Malignant |
|
C6 |
26 |
M |
4 |
Kidney |
Nephroblastoma |
– |
– |
Malignant |
|
C7 |
27 |
M |
4 |
Kidney |
Nephroblastoma |
– |
– |
Malignant |
|
C8 |
28 |
M |
4 |
Kidney |
Nephroblastoma |
– |
– |
Malignant |
|
C9 |
29 |
M |
13 |
Kidney |
Nephroblastoma |
– |
– |
Malignant |
|
C10 |
30 |
M |
13 |
Kidney |
Nephroblastoma |
– |
– |
Malignant |
|
D1 |
31 |
M |
26 |
Kidney |
Nephroblastoma |
– |
– |
Malignant |
|
D2 |
32 |
M |
26 |
Kidney |
Nephroblastoma |
– |
– |
Malignant |
|
D3 |
33 |
M |
22 |
Kidney |
Nephroblastoma |
– |
– |
Malignant |
|
D4 |
34 |
M |
22 |
Kidney |
Nephroblastoma |
– |
– |
Malignant |
|
D5 |
35 |
F |
4 |
Kidney |
Nephroblastoma |
– |
– |
Malignant |
|
D6 |
36 |
F |
4 |
Kidney |
Nephroblastoma |
– |
– |
Malignant |
|
D7 |
37 |
F |
4 |
Kidney |
Nephroblastoma |
– |
– |
Malignant |
|
D8 |
38 |
F |
4 |
Kidney |
Nephroblastoma |
– |
– |
Malignant |
|
D9 |
39 |
F |
21 |
Kidney |
Normal renal tissue |
– |
– |
Normal |
|
D10 |
40 |
F |
21 |
Kidney |
Normal renal tissue |
– |
– |
Normal |
|
E1 |
41 |
M |
48 |
Kidney |
Normal renal tissue |
– |
– |
Normal |
|
E2 |
42 |
M |
48 |
Kidney |
Normal renal tissue |
– |
– |
Normal |
|
E3 |
43 |
F |
12 |
Adrenal gland |
Neuroblastoma |
– |
– |
Malignant |
|
E4 |
44 |
F |
12 |
Adrenal gland |
Neuroblastoma |
– |
– |
Malignant |
|
E5 |
45 |
F |
2 |
Mediastinum |
Neuroblastoma |
– |
– |
Malignant |
|
E6 |
46 |
F |
2 |
Mediastinum |
Neuroblastoma |
– |
– |
Malignant |
|
E7 |
47 |
F |
18 |
Adrenal gland |
Neuroblastoma |
– |
– |
Malignant |
|
E8 |
48 |
F |
18 |
Adrenal gland |
Neuroblastoma with massive necrosis |
– |
– |
Malignant |
|
E9 |
49 |
M |
6 |
Adrenal gland |
Neuroblastoma with necrosis |
– |
– |
Malignant |
|
E10 |
50 |
M |
6 |
Adrenal gland |
Neuroblastoma with necrosis |
– |
– |
Malignant |
|
F1 |
51 |
F |
5 |
Adrenal gland |
Neuroblastoma with necrosis |
– |
– |
Malignant |
|
F2 |
52 |
F |
5 |
Adrenal gland |
Neuroblastoma with necrosis |
– |
– |
Malignant |
|
F3 |
53 |
M |
20 |
Adrenal gland |
Neuroblastoma |
– |
– |
Malignant |
|
F4 |
54 |
M |
20 |
Adrenal gland |
Neuroblastoma |
– |
– |
Malignant |
|
F5 |
55 |
M |
21 |
Nose |
Neuroblastoma |
– |
– |
Malignant |
|
F6 |
56 |
M |
21 |
Nose |
Neuroblastoma |
– |
– |
Malignant |
|
F7 |
57 |
M |
21 |
Nose |
Neuroblastoma |
– |
– |
Malignant |
|
F8 |
58 |
M |
21 |
Nose |
Neuroblastoma |
– |
– |
Malignant |
|
F9 |
59 |
F |
25 |
Abdominal cavity |
Neuroblastoma |
– |
– |
Malignant |
|
F10 |
60 |
F |
25 |
Abdominal cavity |
Neuroblastoma |
– |
– |
Malignant |
|
G1 |
61 |
F |
25 |
Pelvic cavity |
Neuroblastoma |
– |
– |
Malignant |
|
G2 |
62 |
F |
25 |
Pelvic cavity |
Neuroblastoma |
– |
– |
Malignant |
|
G3 |
63 |
M |
50 |
Nerve |
Normal peripheral nerve tissue |
– |
– |
Normal |
|
G4 |
64 |
M |
50 |
Nerve |
Normal peripheral nerve tissue |
– |
– |
Normal |
|
G5 |
65 |
F |
15 |
Nerve |
Normal peripheral nerve tissue |
– |
– |
Normal |
|
G6 |
66 |
F |
15 |
Nerve |
Normal peripheral nerve tissue |
– |
– |
Normal |
|
G7 |
67 |
F |
19 |
Lymph node |
Acute lymphocytic leukaemia |
– |
– |
Malignant |
|
G8 |
68 |
F |
19 |
Lymph node |
Acute lymphocytic leukaemia |
– |
– |
Malignant |
|
G9 |
69 |
F |
10 |
Lymph node |
Acute lymphocytic leukaemia |
– |
– |
Malignant |
|
G10 |
70 |
F |
10 |
Lymph node |
Acute lymphocytic leukaemia |
– |
– |
Malignant |
|
H1 |
71 |
F |
39 |
Lymph node |
Chronic lymphocytic leukaemia |
– |
– |
Malignant |
|
H2 |
72 |
F |
39 |
Lymph node |
Chronic lymphocytic leukaemia |
– |
– |
Malignant |
|
H3 |
73 |
M |
56 |
Spleen |
Chronic lymphocytic leukaemia |
– |
– |
Malignant |
|
H4 |
74 |
M |
56 |
Spleen |
Chronic lymphocytic leukaemia |
– |
– |
Malignant |
|
H5 |
75 |
M |
32 |
Bone |
Acute granulocytic leukemia |
– |
– |
Malignant |
|
H6 |
76 |
M |
32 |
Bone |
Acute granulocytic leukemia |
– |
– |
Malignant |
|
H7 |
77 |
M |
30 |
Spleen |
Normal spleen tissue |
– |
– |
Normal |
|
H8 |
78 |
M |
30 |
Spleen |
Normal spleen tissue |
– |
– |
Normal |
|
H9 |
79 |
M |
30 |
Spleen |
Normal spleen tissue |
– |
– |
Normal |
|
H10 |
80 |
M |
30 |
Spleen |
Normal spleen tissue |
– |
– |
Normal |
|
–
|
– |
M |
42 |
Adrenal gland |
Pheochromocytoma (tissue marker) |
|
|
Malignant |
† For precise diagnosis, refer to pathology description.
TNM grading:
T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum
N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes
M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis
|
|